Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Maxim Group Downgrades New York Mortgage Trust (NYMT) to Hold
-
Maxim Group Downgrades American Capital Agency (AGNC) to Hold
-
LM Funding Announces Business Combination Agreement With Hanfor and Concurrent $1.25 Million Private Placement of Common Stock
-
Summit Wireless Raises $1.7M in Private Placement of a Senior Secured Convertible Security
-
Manhattan Bridge Capital Inc (LOAN) PT Lowered to $6 at Maxim Group, Following Earnings
-
Garrison Capital (GARS) PT Lowered to $6.50 at Maxim Group, Following Earnings
-
Daxor Corp. (DXR) Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market
-
Daxor Corporation Announces Closing of $2.0 Million Registered Direct Offering Priced At-The-Market
-
Daxor Corporation Announces Closing of $2.0 Million Registered Direct Offering Priced At-The-Market
-
Heat Biologics (HTBX) PT Raised to $2 at Maxim Group
-
Splunk (SPLK) PT Raised to $185 at Maxim Group
-
Biocept (BIOC) Announces Pricing of $6.6 Million Registered Direct Offering of Common Stock
-
Biocept Announces Pricing of $6.6 Million Registered Direct Offering Priced At-The-Market
-
Pre-Open Stock Movers 03/03: (MITO) (INO) (WIFI) Higher; (CODX) (TLRY) (KPTI) Lower (more...)
-
Lipidio Pharmaceuticals Launches with First Close of Series A Financing
-
Maxim Group Downgrades Co-Diagnostics (CODX) to Hold
-
Heat Biologics (HTBX) Files Patent Related to Coronavirus - Maxim Group
-
Co-Diagnostics (CODX) Announces Closing of $4.2 Million Registered Direct Offering Priced At-the-Market
-
Co-Diagnostics Announces Closing of $4.2 Million Registered Direct Offering Priced At-the-Market
-
NLS Pharmaceutics Ltd. (NLS) Files Registration Statement for a Proposed Initial Public Offering
-
Biocept (BIOC) Prices 23M Share Registered Direct Offering at $0.40/Sh
-
Biocept Announces Pricing of $9.2 Million Registered Direct Offering Priced At-The-Market
-
Aptorum Group Announces Closing of $10 Million Registered Direct Offering of Class A Ordinary Shares and Warrants
-
Lianluo Smart Limited (LLIT) Prices 4.9M Class A Share Offering at $0.70/Sh
-
Lianluo Smart Limited Announces Pricing of Approximately $3.4 Million Offering
-
Co-Diagnostics (CODX) Announces $4.2 Million Registered Direct Offering Priced At-the-Market
-
Co-Diagnostics Announces $4.2 Million Registered Direct Offering Priced At-the-Market
-
Aptorum Group Limited (APM) Prices $10 Million Registered Direct Offering of Ordinary Shares and Warrants
-
Aptorum Group Announces Pricing of $10 Million Registered Direct Offering
-
ContraFect Corp. (CFRX) PT Raised to $22 at Maxim Group
-
Adamis Pharmaceuticals (ADMP) Prices $6.7M Registered Direct Offering
-
Adamis Pharmaceuticals Announces Pricing of $6.7 Million Registered Direct Offering
-
Agile Therapeutics (AGRX) Prices 15M Share Offering at $3/Sh
-
UPDATE: Lianluo Smart Limited (LLIT) Prices 3.5M Class A Share Offering at $0.70/Sh
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Lianluo Smart Limited Announces Pricing of Approximately $2.5 Million Offering
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Agile Therapeutics (AGRX) to Offer Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Maxim Group Starts Aptose Biosciences (APTO) at Buy
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Euroseas Ltd. (ESEA) PT Lowered to $5 at Maxim Group, Following Earnings
-
Medalist Diversified REIT Closes $4.6 Million Underwritten Public Offering of Series A Preferred Stock
-
Yunhong International Announces Closing of Upsized $60 Million Initial Public Offering
-
Aridis Pharmaceuticals to Host Investor Day Showcasing APEX™ Technology Platform and Key Opinion Leader Panels on Cystic Fibrosis and Pneumonia
-
Churchill Capital Corp III Announces Pricing of $1 Billion Initial Public Offering


